These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15490456)

  • 1. Electrophoretic separation of amyloid beta peptides in plasma.
    Lewczuk P; Esselmann H; Bibl M; Paul S; Svitek J; Miertschischk J; Meyrer R; Smirnov A; Maler JM; Klein C; Otto M; Bleich S; Sperling W; Kornhuber J; Rüther E; Wiltfang J
    Electrophoresis; 2004 Oct; 25(20):3336-43. PubMed ID: 15490456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
    Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
    Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species.
    Maler JM; Klafki HW; Paul S; Spitzer P; Groemer TW; Henkel AW; Esselmann H; Lewczuk P; Kornhuber J; Wiltfang J
    Proteomics; 2007 Oct; 7(20):3815-20. PubMed ID: 17924594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
    Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoterminally truncated and oxidized amyloid-β peptides in the cerebrospinal fluid of Alzheimer's disease patients.
    Bibl M; Gallus M; Welge V; Esselmann H; Wiltfang J
    J Alzheimers Dis; 2012; 29(4):809-16. PubMed ID: 22460324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    Bibl M; Esselmann H; Mollenhauer B; Weniger G; Welge V; Liess M; Lewczuk P; Otto M; Schulz JB; Trenkwalder C; Kornhuber J; Wiltfang J
    J Neurochem; 2007 Oct; 103(2):467-74. PubMed ID: 17662050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.
    Portelius E; Zetterberg H; Andreasson U; Brinkmalm G; Andreasen N; Wallin A; Westman-Brinkmalm A; Blennow K
    Neurosci Lett; 2006 Dec; 409(3):215-9. PubMed ID: 17049739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
    Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
    Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.
    Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF
    Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment.
    Mamo JC; Jian L; James AP; Flicker L; Esselmann H; Wiltfang J
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):395-403. PubMed ID: 18583625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
    Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
    Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43.
    Wiltfang J; Smirnov A; Schnierstein B; Kelemen G; Matthies U; Klafki HW; Staufenbiel M; Hüther G; Rüther E; Kornhuber J
    Electrophoresis; 1997; 18(3-4):527-32. PubMed ID: 9150936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.
    Anderson JJ; Holtz G; Baskin PP; Turner M; Rowe B; Wang B; Kounnas MZ; Lamb BT; Barten D; Felsenstein K; McDonald I; Srinivasan K; Munoz B; Wagner SL
    Biochem Pharmacol; 2005 Feb; 69(4):689-98. PubMed ID: 15670587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology.
    Maddalena AS; Papassotiropoulos A; Gonzalez-Agosti C; Signorell A; Hegi T; Pasch T; Nitsch RM; Hock C
    Neurodegener Dis; 2004; 1(4-5):231-5. PubMed ID: 16908995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies.
    Lanz TA; Schachter JB
    J Neurosci Methods; 2008 Mar; 169(1):16-22. PubMed ID: 18160105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.